Newsfeed : British HIV Groups Say PrEP Should Not Be Offered Yet

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » March 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 5, 2012

British HIV Groups Say PrEP Should Not Be Offered Yet

The British HIV Association (BHIVA) and the British Association for Sexual Health and HIV (BASHH) have issued a statement saying that efficacy data on pre-exposure prophylaxis (PrEP) is not compelling enough for PrEP to be offered to patients on demand, aidsmap reports. PrEP is given to HIV-negative people who are at high risk for the virus. They take antiretroviral medications daily in an effort to lower their risk. The BHIVA/BASHH statement contrasts with guidelines issued by the U.S. Centers for Disease Control and Prevention, which support providing PrEP for men who have sex with men. According to the BHIVA/BASHH statement, the increased rate of new HIV cases in the United Kingdom points to a need for a new HIV prevention strategy. The statement also points out that there are too many unanswered questions about PrEP, including how much will it cost, will it lead to drug resistance, will it encourage people to not use condoms, and will it lead to long-term drug toxicity.  

To read the aidsmap article, click here.

Search: The British HIV Association, BHIVA, the British Association for Sexual Health and HIV, BASHH, HIV, PrEP, AIDS, health


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    oceanblue65
    louisiana
    Louisiana


    Deelight4u
    BROOKLYN
    New York


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.